◆#mrna

2 articles

Markets

Moderna Stock Drops 25% Despite Positive Phase 3 Cancer Vaccine Trial Data

Oct 23, 2026·3m read

Markets

Moderna Surges 663% in 2026 to Become Top S&P 500 Stock Ahead of Cancer Data

Oct 10, 2026·3m read